Volume 6, Issue 3 (9-2016)                   Iran J Ped Hematol Oncol 2016, 6(3): 182-189 | Back to browse issues page

XML Print


Associate Professor of Medical Genetics (MD-PhD), Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran
Abstract:   (5208 Views)

Abstract

Background: Haemophilia A (HA) is an X-linked bleeding disorder caused by the absence or reduced activity of coagulation factor VIII (FVIII). Coagulation factors are a group of related proteins that are essential for the formation of blood clots. The aim of this study was to genotype the coagulation factor VIII gene mutations using Inverse Shifting PCR (IS-PCR) in an Iranian family with severe Haemophilia A.

Material and Methods: Genomic DNA was extracted from blood of Iranian family members with severe hemophilia A and then was genotyped using specific primers by Inverse Shifting PCR method and was analyzed by sequencing for all FVIII exons.

Results: Sequence analysis of F8 gene revealed two distinct mutations. The first mutation was a C-to-G transition at 3780 position in exon 14, which cause an Asp1240 Glu in the region encoding the B domain of FVIII. It seems that this mutation could be a polymorphism. The second mutation was a 2-bp AA deletion in exon 18 (nt. 5820-5823, del. AA). The patient's mother and sister were also heterozygous for 2bp AA deletion. This deletion caused a frame shift in exon 18 and terminated after 29 amino acids for a premature stop codon.

Conclusions: Based on the results, it can be concluded that two IS-PCR and genomic sequencing techniques are robust and low cost method that facilitates the analysis of HA patients and carrier detection.

Full-Text [PDF 690 kb]   (2935 Downloads)    
Type of Study: Research | Subject: Heart
Received: 2016/03/26 | Accepted: 2016/07/10 | Published: 2016/09/3

References
1. Flood E, Pocoski J, Michaels LA, Bell JA, Valluri S, Sasanè R. Illustrating the impact of mild/moderate and severe haemophilia on health-related quality of life: hypothesised conceptual models. European Journal of Haematology. 2014; 93(75):9–18. [Article]
2. Berntorp, E., &Shapiro, A.D. Modern haemophilia care. The Lancet. 2012, 379(9824):1447-56. [Article]
3. Tantawy AG. Molecular genetics of hemophilia A: Clinical perspectives. Egyptian Journal of Medical Human Genetics, 2010 Nov 3;11(2):105-14. [Article]
4. Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. European Journal of Human Genetics, 2007 Jun;15(6):628-37. [Article]
5. Konkle BA, Josephson NC, Fletcher SN, Hemophilia A. GeneReviews [Internet]. 2014 Jun 5. [Article]
6. Kessler L, Adams R, Mighion L, Walther S, Ganguly A. Prenatal diagnosis in haemophilia A: experience of the genetic diagnostic laboratory. Haemophilia, 2014 Nov;20(6):384-91. [Article]
7. Lam EPT. Clinical Applications of Molecular Technologies in Hematology. Journal of Medical Diagnostic Methods. 2013 Aug 16;4;2(4):2-6. [Article]
8. Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, Váradi A, Tordai A. Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica. 2003 Jul 21;88(7):778-84. [Article]
9. Rossetti LC, Radic CP, Abelleyro MM, Larripa IB, De Brasi CD. Eighteen years of molecular genotyping the hemophilia inversion hotspot: From southern blot to inverse shifting-PCR. International Journal of Molecular Science. 2011 Oct 24;12(10):7271-85 [Article]
10. Rossetti LC, Radic CP, Larripa IB, De Brasi CD. Genotyping the hemophilia inversion hotspot by use of inverse PCR. Clinical Chemistry. 2005 Jul 3;51(7):1154-8. [Article]
11. Miyawaki Y, Suzuki A, Fujimori Y, Takagi A. Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation. International Journal of Hematology. 2010 Sep 22;92(2):405-8. [Article]
12. Oldenburg J, Ananyeva NM, Saenko EL. Molecular basis of haemophilia A. Haemophilia. 2004 Oct 4;10 (4):133-9. [Article]
13. Sabatino DE, Nichols TC, Merricks E, Bellinger DA. Animal models of hemophilia. Progress in Molecular Biology and Translational Science. 2012;105:151-209. [Article]
14. El-Maarri O, Herbiniaux U, Graw J, Schröder J, Terzic A, Watzka M, et al.. Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. Journal of Thrombosis and Haemostosis. 2005 Feb 3;(2):332-9. [Article]
15. Bagnall RD, Waseem N, Green PM, Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood. 2002 Jan 1;99(1):168-74. [Article]
16. Traystman MD, Higuchi M, Kasper CK, Antonarakis SE, Kazazian HH Jr. Use of denaturing gradient gel electrophoresis to detect point mutations in the factor VIII gene. Genomics. 1990 Feb 6;(2):293-301. [Article]
17. Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian HH Jr, Antonarakis SE. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. American Journal of Human Genetics. 1997 Mar 6;60(3):565-73. [Article]
18. Kazazian HH Jr, Wong C, Youssoufian H, Scott AF, Phillips DG, Antonarakis SE. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature. 1988 Mar 10;332(6160):164-6. [Article]
19. Fujita J, Miyawaki Y, Suzuki A, Maki A, Okuyama E, Murata M, A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors. Journal of Thrombosis and Haemostosis. 2012 Oct 10;(10):2099-2107. [Article]
20. Roozafzay N, Kokabee L, Zeinali S, Karimipoor M. Analysis of Intron 1 Inversion at F8 Gene in Severe Hemophilia A Patients by Inverse Shifting-PCR Referred from Isfahan Seyedolshohada Hospital. Journal of Ardabil University of Medical Science. 2013 May 13 (1):93-101. [Article]
21. Pan TY, Chiou SS, Wang CC, Wu SM. Separation of intron 22 inversion type 1 and 2 of hemophilia A by modified inverse-shifting polymerase chain reaction and capillary gel electrophoresis. Talanta. 2014 Dec 4;130:328-35. [Article]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.